Anvendelse av agomelatin for å oppnå medikamenter tiltenkt for behandlingen av Smith-Magenis syndrom

• 收藏
• 分享

专利权人:

Les Laboratoires Servier

发明人:

Mocaer, Elisabeth,Fabiano, Agnes

申请号：

NO20075989

公开号：

NO338951B1

申请日:

2007.11.23

申请国别(地区):

NO

年份:

2016

代理人:

摘要：

Use of agomelatine (I) or its hydrates, crystalline forms and acid or base addition salts, to obtain a drug to treat Smith Magenis syndrome, is claimed. An independent claim is included for a composition comprising (I) optionally in combination with excipients. ACTIVITY : Antidepressant Hypnotic Cardiovascular-Gen. Anorectic. MECHANISM OF ACTION : 5-Hydroxytryptamine-2C antagonist Melatoninergic receptor agonist.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/